Chemoinformaics analysis of 9-O-Demethylhomolycorine
| Molecular Weight | 301.342 | nRot | 1 |
| Heavy Atom Molecular Weight | 282.19 | nRig | 21 |
| Exact Molecular Weight | 301.131 | nRing | 4 |
| Solubility: LogS | -3.092 | nHRing | 2 |
| Solubility: LogP | 2.164 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 19 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 45.3671 |
| nHD | 1 | BPOL | 25.1109 |
| QED | 0.635 |
| Synth | 4.003 |
| Natural Product Likeliness | 2.438 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.018 |
| HIA | 0.06 |
| CACO-2 | -4.521 |
| MDCK | 0.0000181 |
| BBB | 0.995 |
| PPB | 0.701773 |
| VDSS | 1.989 |
| FU | 0.234527 |
| CYP1A2-inh | 0.082 |
| CYP1A2-sub | 0.598 |
| CYP2c19-inh | 0.032 |
| CYP2c19-sub | 0.854 |
| CYP2c9-inh | 0.039 |
| CYP2c9-sub | 0.619 |
| CYP2d6-inh | 0.792 |
| CYP2d6-sub | 0.858 |
| CYP3a4-inh | 0.137 |
| CYP3a4-sub | 0.532 |
| CL | 14.906 |
| T12 | 0.631 |
| hERG | 0.025 |
| Ames | 0.033 |
| ROA | 0.838 |
| SkinSen | 0.041 |
| Carcinogencity | 0.927 |
| EI | 0.014 |
| Respiratory | 0.92 |
| NR-Aromatase | 0.003 |
| Antiviral | Yes |
| Prediction | 0.724667 |